Literature DB >> 4070918

Variations in host responses and the pathogenesis of human onchocerciasis.

C D Mackenzie, J F Williams, B M Sisley, M W Steward, J O'Day.   

Abstract

Different immune responses to Onchocerca volvulus cause considerable variation in clinical manifestations of human onchocerciasis. Onchocercal lesions result from inflammatory reactions involving immunologic mechanisms; the role of the immune system in pathogenesis is emphasized by the phenomena accompanying accelerated worm destruction during microfilaricidal chemotherapy (e.g., eosinophilia, changes in total immunoglobulin level, and anaphylactic symptoms). Although most pathologic changes are associated with the microfilarial stage, the extent to which circulating antibodies are directed against antigens in the adult worm or its uterine constituents is unknown. Microfilarial destruction can be mediated by antibody to the surface-associated antigens of the worms and enhanced by complement; a correlation exists between the presence of these antibodies and punctate keratitis. Heterogeneous immunologic components are associated with the surface of dermal and nodular microfilariae in vivo. Preliminary findings indicate that the level of O. volvulus-specific immune complexes is inversely proportional to the microfilarial load. To monitor a patient's clinical status and immunologic response, a quantitative system dividing symptoms into those associated with active responses to the microfilariae and those representing long-term consequences of these reactions is suggested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4070918     DOI: 10.1093/clinids/7.6.802

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  12 in total

1.  Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy.

Authors:  D O Freedman; A Lujan-Trangay; C Steel; C Gonzalez-Peralta; T B Nutman
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

2.  Interleukin-12 modulates T-cell responses to microfilariae but fails to abrogate interleukin-5-dependent immunity in a mouse model of onchocerciasis.

Authors:  P J Hogarth; A E Bianco
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

3.  A histocytochemical study of the macrophages present in tissue responses to adult Onchocerca volvulus.

Authors:  A J Gatrill; C D Mackenzie; J E McMahon; J F Williams; R H Guderian
Journal:  Histochem J       Date:  1987-09

4.  Isolation and characterization of expression cDNA clones encoding antigens of Onchocerca volvulus infective larvae.

Authors:  T R Unnasch; M Y Gallin; P T Soboslay; K D Erttmann; B M Greene
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

5.  Unique recognition of a low molecular weight Onchocerca volvulus antigen by IgG3 antibodies in chronic hyper-reactive oncho-dermatitis (Sowda).

Authors:  Z Cabrera; D W Buttner; R M Parkhouse
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

Review 6.  Clinical and laboratory aspects of filariasis.

Authors:  J Nanduri; J W Kazura
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

7.  Tropomyosin implicated in host protective responses to microfilariae in onchocerciasis.

Authors:  R E Jenkins; M J Taylor; N J Gilvary; A E Bianco
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

8.  Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis.

Authors:  M Y Elkhalifa; H W Ghalib; T Dafa'Alla; J F Williams
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

9.  Epitopes of the Onchocerca volvulus RAL1 antigen, a member of the calreticulin family of proteins, recognized by sera from patients with onchocerciasis.

Authors:  L A Rokeach; P A Zimmerman; T R Unnasch
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?

Authors:  Natalie V S Vinkeles Melchers; Wilma A Stolk; Michele E Murdoch; Belén Pedrique; Marielle Kloek; Roel Bakker; Sake J de Vlas; Luc E Coffeng
Journal:  PLoS Negl Trop Dis       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.